Laboratory Evaluation of Three Regimens of Treatment of Chronic Hepatitis B: Tenofovir, Entecavir and Combination of Lamivudine and Adefovir

BACKGROUND: Chronic hepatitis B is a disease of concern due to its life-threatening complications like cirrhosis, and hepatocellular carcinoma (HCC) in 20-40% of patients. There are about 400 million people affected worldwide with HBV, and over 300,000 die every year from HBV-related diseases. Oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayakumar, Rajeswari, Joshi, Yogendra Kumar, Singh, Sarman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425258/
https://www.ncbi.nlm.nih.gov/pubmed/22923916
http://dx.doi.org/10.4103/0974-2727.98664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425258/
https://www.ncbi.nlm.nih.gov/pubmed/22923916
http://dx.doi.org/10.4103/0974-2727.98664

Ejemplares similares